rs137852593
|
|
Malignant neoplasm of prostate
|
|
0.740 |
GeneticVariation
|
BEFREE |
The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.
|
11103816 |
2000 |
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.
|
11103816 |
2000 |
rs137852593
|
|
Primary malignant neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.
|
11103816 |
2000 |
rs137852593
|
|
Malignant Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.
|
11103816 |
2000 |
rs137852593
|
|
Malignant neoplasm of prostate
|
|
0.740 |
GeneticVariation
|
BEFREE |
R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
|
12539229 |
2003 |
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
|
12539229 |
2003 |
rs137852593
|
|
Prostate cancer, familial
|
|
0.010 |
GeneticVariation
|
BEFREE |
The AR R726L allele does not account for a significant proportion of early-onset and/or familial prostate cancer in the United States.
|
12539229 |
2003 |
rs137852593
|
|
Malignant neoplasm of prostate
|
|
0.740 |
GeneticVariation
|
BEFREE |
To estimate the possible involvement of the prostate cancer predisposing AR Arg726Leu germ-line mutation in MBC, this mutation was tested in 117 MBC patients.
|
12602915 |
2003 |
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
To estimate the possible involvement of the prostate cancer predisposing AR Arg726Leu germ-line mutation in MBC, this mutation was tested in 117 MBC patients.
|
12602915 |
2003 |
rs137852593
|
|
Carcinoma of Male Breast
|
|
0.010 |
GeneticVariation
|
BEFREE |
To estimate the possible involvement of the prostate cancer predisposing AR Arg726Leu germ-line mutation in MBC, this mutation was tested in 117 MBC patients.
|
12602915 |
2003 |
rs137852593
|
|
Malignant neoplasm of male breast
|
|
0.010 |
GeneticVariation
|
BEFREE |
To estimate the possible involvement of the prostate cancer predisposing AR Arg726Leu germ-line mutation in MBC, this mutation was tested in 117 MBC patients.
|
12602915 |
2003 |
rs137852593
|
|
Malignant neoplasm of prostate
|
|
0.740 |
GeneticVariation
|
BEFREE |
R726L substitution in the hormone binding region of androgen receptor was found in 1 prostate cancer family but no previously uncharacterized germline mutations were detected.
|
14665948 |
2004 |
rs137852593
|
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
R726L substitution in the hormone binding region of androgen receptor was found in 1 prostate cancer family but no previously uncharacterized germline mutations were detected.
|
14665948 |
2004 |